Trials / Completed
CompletedNCT00141817
Study Evaluating Pantoprazole in Children With GERD
A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of Pantoprazole Sodium in Children Aged 1 Through 11 Years With Endoscopically Proven GERD
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 1 Year – 11 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the PK profile, safety and tolerability of single and multiple doses of pantoprazole in children aged 1 through 11 years with endoscopically proven GERD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pantoprazole for approximately 9 weeks. |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2005-09-01
- Last updated
- 2011-12-28
- Results posted
- 2011-12-28
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00141817. Inclusion in this directory is not an endorsement.